BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lei XF, Ke Y, Bao TH, Tang HR, Wu XS, Shi ZT, Lin J, Zhang ZX, Gu H, Wang L. Effect and safety of sorafenib in patients with intermediate hepatocellular carcinoma who received transarterial chemoembolization: A retrospective comparative study. World J Clin Cases 2018; 6(5): 74-83 [PMID: 29774219 DOI: 10.12998/wjcc.v6.i5.74]
URL: https://www.wjgnet.com/1948-5182/full/v6/i5/74.htm
Number Citing Articles
1
Chiuyen Phan, Ziyang Zheng, Jianwei Wang, Qiwen Wang, Xiurong Hu, Guping Tang, Hongzhen Bai. Enhanced antitumour effect for hepatocellular carcinoma in the advanced stage using a cyclodextrin-sorafenib-chaperoned inclusion complexBiomaterials Science 2019; 7(11): 4758 doi: 10.1039/C9BM01190K
2
Daniel H. Palmer, Katerina Malagari, Laura M. Kulik. Role of locoregional therapies in the wake of systemic therapyJournal of Hepatology 2020; 72(2): 277 doi: 10.1016/j.jhep.2019.09.023
3
Tao Zhang, Weisen Huang, Haorong Dong, Yijun Chen. Trans-catheter arterial chemoembolization plus Sorafenib, an unsuccessful therapy in the treatment of hepatocellular carcinoma?Medicine 2020; 99(29): e20962 doi: 10.1097/MD.0000000000020962
4
Zhoujing Cheng, Lin He, Yingjie Guo, Yuhua Song, Shasha Song, Lijiu Zhang. The combination therapy of transarterial chemoembolisation and sorafenib is the preferred palliative treatment for advanced hepatocellular carcinoma patients: a meta-analysisWorld Journal of Surgical Oncology 2020; 18(1) doi: 10.1186/s12957-020-02017-0
5
María Hernández‑bule, María Martínez, María Trillo, Lidia Martínez, Elena Toledano‑Macías, Alejandro Úbeda. Response of human cancer cells to simultaneous treatment with sorafenib and radiofrequency currentOncology Letters 2021; 22(5) doi: 10.3892/ol.2021.13068
6
Ao Huang, Xin-Rong Yang, Wen-Yuan Chung, Ashley R. Dennison, Jian Zhou. Targeted therapy for hepatocellular carcinomaSignal Transduction and Targeted Therapy 2020; 5(1) doi: 10.1038/s41392-020-00264-x